Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease

Systemic sclerosis-related interstitial lung disease (SSc-ILD) is the leading cause of death in SSc. In this study, we aimed to describe the baseline severity and evolution of forced vital capacity (FVC) and diffusing capacity for carbon monoxide (DLCO) in patients with SSc-ILD and to assess the bas...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2017-08, Vol.12 (8), p.e0181692-e0181692
Hauptverfasser: Le Gouellec, Noémie, Duhamel, Alain, Perez, Thierry, Hachulla, Anne-Lise, Sobanski, Vincent, Faivre, Jean-Baptiste, Morell-Dubois, Sandrine, Lambert, Marc, Hatron, Pierre-Yves, Hachulla, Eric, Béhal, Hélène, Matran, Regis, Launay, David, Remy-Jardin, Martine
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Systemic sclerosis-related interstitial lung disease (SSc-ILD) is the leading cause of death in SSc. In this study, we aimed to describe the baseline severity and evolution of forced vital capacity (FVC) and diffusing capacity for carbon monoxide (DLCO) in patients with SSc-ILD and to assess the baseline clinical, biological and high-resolution CT scan (HRCT) predictors of this evolution. Baseline and serial FVC and DLCO were collected in 75 SSc-ILD patients followed during 6.4±4.2 years (n = 557 individual data). FVC and DLCO evolution was modelled using a linear mixed model with random effect. During follow-up, FVC was stable while DLCO significantly decreased (-1.5±0.3%/year (p
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0181692